Tolemy Bio is developing Orbit, an AI-native system that connects laboratory tools and experimental data sources while incorporating virtual cell models and AI research agents to help scientists analyse cellular behaviour and guide experiments. The company aims to consolidate fragmented research data spread across spreadsheets, lab equipment, and notebooks into a single environment to improve reproducibility and decision-making. Its long-term goal is to build a virtual-cell platform that enables more precise, data-driven approaches to therapeutic development and cell control. The startup was founded by Alex Ward and Caelan Anderson and is headquartered in Cambridge, with substantial operations in Barcelona. Tolemy Bio recently raised €1.4 million in pre-seed funding to grow its data generation, machine learning, and engineering teams and to support early customer and partner deployments.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

May 2026